Skip to main content

Table 4 Risk factors associated with critical illness

From: Risk factors for the critical illness in SARS-CoV-2 infection: a multicenter retrospective cohort study

 

Univariable OR (95%CI)

p value

Multivariable OR (95%CI)a

p value

Demographics and clinical characteristics

 Age, years

2.03 (1.61–2.62)

8.92E-09

  

 Baseline(< 30)

1.00 (ref)

   

  30–39

2.27 (0.31–45.77)

0.473534

  

  40–49

1.85 (0.26–37.22)

0.590015

  

  50–59

7.05 (1.25–132.86)

0.069253

  

  60–69

14.29 (2.62–267.08)

0.012654

  

  70–79

55.00 (8.15–1132.20)

0.000512

  

   > 79

25.00 (3.18–538.98)

0.007295

  

 Female sex (vs male)

1.19 (0.65–2.24)

0.58

  

 Dyspnea (vs not dyspnea)

40.56 (16.19–117.96)

1.28E-13

46.01 (15.36–169.48)

2.30E-10

 Respiratory rate > 24 breaths per min (vs respiratory rate ≤ 24 breaths per min)

15.63 (6.34–42.77)

1.07E-08

5.84 (1.53–23.01)

0.00994

Comorbidity present (vs not present)

 Hypertension

3.84 (1.92–7.64)

0.000123

1.45 (0.64–3.19)

0.365

 Diabetes

3.53 (1.28–9.493)

0.0121

1.74 (0.58–5.02)

0.307

 Digestive tract disease

1.29 (0.06–10.29)

0.828

  

 Cardiovascular disease

6.39 (1.76–25.87)

0.00535

1.33 (0.32–6.00)

0.697

 Cerebrovascular disease

7.96 (0.75–173.32)

0.093

  

 Carcinoma

12.18 (1.52–249.22)

0.032

2.57 (0.29–54.99)

0.434

 Liver disease

4.02 (0.73–22.30)

0.0944

  

 Chronic obstructive lung disease

1.29 (0.19–5.81)

0.757

  

Laboratory findings

 White blood cell count (×109/L)

5.56 (2.69–12.43)

9.59E-06

7.11 (3.04–18.43)

1.75E-05

   < 3.5

0.39 (0.09–1.16)

0.131

0.19 (0.03–0.75)

0.034956

  3.5–9.5

1.00 (ref)

 

1.00 (ref)

 

   > 9.5

7.94 (3.19–21.18)

1.43E-05

8.38 (2.82–26.64)

0.00018

 Lymphocyte count (×109/L)

0.33 (0.16–0.64)

0.00144

0.49 (0.23–1.00)

0.0584

   < 1.1

3.68 (1.83–7.94)

0.000452

2.41 (1.09–5.63)

0.0342

  1.1–3.2

1.00 (ref)

 

1.00 (ref)

 

   > 3.2

4.18 (0.19–47.28)

0.258274

1.96 (0.08–26.78)

0.6238

 Neutrophil count (x109/L)

2.81 (1.54–5.31)

0.00106

3.00 (1.50–6.30)

0.00259

   < 1.8

1.00 (0.35–2.49)

0.998

0.94 (0.28–2.77)

0.915091

  1.8–6.3

1.00 (ref)

 

1.00 (ref)

 

   > 6.3

5.13 (2.33–11.44)

5.11E-05

6.03 (2.31–16.18)

0.000268

 Monocyte count(x109/L)

1.35 (0.63–2.81)

0.42501

  

   < 0.1

3.69 (0.14–94.79)

0.36

  

  0.1–0.6

1.00 (ref)

   

   > 0.6

1.53 (0.69–3.21)

0.274

  

 Platelet count (x109/L)

1.16 (0.55–2.57)

0.698881

  

   < 125

1.18 (0.49–2.62)

0.693

  

  125–350

1.00 (ref)

   

   > 350

3.68 (0.66–20.52)

0.119

  

 NLR

3.92 (2.11–7.59)

2.57E-05

4.17 (2.00–9.26)

0.000231

   < 0.78

NAb

0.986

NA

0.98938

  0.78–3.53

1.00 (ref)

 

1.00 (ref)

 

   > 3.53

3.73 (1.96–7.32)

8.52E-05

3.78 (1.73–8.65)

0.00113

 APTT(s)

1.90 (0.92–3.94)

0.082165

  

   < 21

NA

0.985

  

  21–37

1.00 (ref)

   

   > 37

1.48 (0.63–3.30)

0.352

  

 fibrinogen(g/L)

3.06 (1.58–5.99)

0.000969

2.69 (1.27–5.84)

0.01063

   < 2

NA

0.9898

NA

0.9874

  2–4

1.00 (ref)

 

1.00 (ref)

 

   > 4

2.90 (1.46–5.77)

0.0023

2.38 (1.07–5.33)

0.0334

 D-dimer (μg/mL)

2.52 (1.29–4.96)

0.00699

2.52 (1.14–5.63)

0.0228

 ESR (mm/1 h)

2.18 (1.05–4.54)

0.0364

2.54 (0.99–6.65)

0.052685

 Procalcitonin (ng/mL)

4.40 (1.77–13.36)

0.00337

2.83 (1.03–9.34)

0.0598

 CRP (mg/L)

2.02 (1.04–4.09)

0.0434

1.68 (0.76–3.90)

0.210687

 Lactate dehydrogenase (U/L)

2.16 (1.16–4.13)

0.0172

1.47 (0.71–3.12)

0.30

   < 91

0.34 (0.012–1.84)

0.3101

0.38 (0.02–2.56)

0.407692

  91–230

1.00 (ref)

 

1.00 (ref)

 

   > 230

2.04 (0.98–4.22)

0.0539

1.29 (0.53–3.08)

0.563397

 Creatine kinase (U/L)

1.77 (0.82–3.72)

0.136

  

 Creatinine (μmol/L)

1.67 (0.62–4.73)

0.3153

  

   < 44

1.27 (0.26–4.77)

0.7402

  

  44–112

1.00 (ref)

   

   > 112

2.95 (0.79–11.09)

0.0987

  

 BUN (mmol/L)

8.09 (2.84–29.37)

0.000331

9.20 (2.87–38.15)

0.000611

   < 2.5

0.67 (0.10–2.76)

0.622078

0.54 (0.05–3.14)

0.54405

  2.5–7.1

1.00 (ref)

 

1.00 (ref)

 

   > 7.1

18.16 (4.68–120.23)

0.000229

18.57 (4.23–133.27)

0.00053

 AST (U/L)

2.30 (1.19–4.44)

0.0131

2.29 (1.05–5.03)

0.036656

 ALT(U/L)

2.28 (1.09–4.70)

0.0269

3.67 (1.45–9.47)

0.00615

 Total bilirubin (μmol/L)

5.71 (2.47–13.68)

5.84E-05

5.53 (2.12–14.92)

0.000548

   < 3

NA

0.989

NA

0.990348

  3–21

1.00 (ref)

 

1.00 (ref)

 

   > 21

5.60 (2.40–13.50)

8.12E-05

5.50 (2.10–14.88)

0.000584

 SOFA score

2.88 (2.10–4.16)

1.15E-09

2.77 (1.95–4.16)

1.20E-07

  0

1.00 (ref)

 

1.00 (ref)

 

  1

NA

0.99253

NA

0.992699

  2

14.68 (3.43–102.01)

0.00112

10.72 (2.25–79.00)

0.006283

  3

36.64 (8.66–256.66)

1.34E-05

35.09 (6.91–279.80)

9.44E-05

  4

108.50 (16.22–1247.72)

1.34E-05

73.50 (9.45–9.52)

0.000177

  5

403.00 (49.95–9761.98)

2.01E-06

474.72 (38.22–27,290.59)

8.24E-05

  6

NA

0.99582

NA

0.996041

  7

NA

0.99759

NA

0.998477

  1. OR Odds ratio, NLR Neutrophil-to-lymphocyte ratio, APTT Activated partial thromboplastin time, FIB Fibrinogen, ESR Erythrocyte sedimentation rate, PCT Procalcitonin, CRP C-reactive protein, LDH Lactate dehydrogenase, CK Creatine kinase, BUN Blood urea nitrogen, AST Aspartate transaminase, ALT Alanine aminotransferase, TBIL Total bilirubin, SOFA Sequential Organ Failure Assessment
  2. a Independent risk factors were identified with multivariable logistic regression adjusted for potential confounders (details in supplementary material)
  3. bToo few cases